Evidence map›Paper›PMID 35805065›Full record

ArticleCancers2022

Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.

Ken Kudura, Florentia Dimitriou, Lucas Basler, Robert Förster, Daniela Mihic-Probst, Tim Kutzker, Reinhard Dummer, Joanna Mangana, Irene A Burger, Michael C Kreissl

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ken KuduraDepartment of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.
Florentia DimitriouDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Lucas BaslerCenter for Proton Therapy, Paul Scherrer Institute, 5232 Villigen, Switzerland.
Robert FörsterInstitute of Radiation Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.ORCID 0000-0002-7664-9207
Daniela Mihic-ProbstInstitute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-2215-9958
Tim KutzkerFaculty of Applied Statistics, Humboldt University Berlin, 10117 Berlin, Germany.
Reinhard DummerDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-2279-6906
Joanna ManganaDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Irene A BurgerDepartment of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0001-8029-8692
Michael C KreisslDepartment of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.

Funding

Cancer Research Center, Comprehensive Center Zurich, University Hospital Zurich CRC_13Iten-Kohaut-Foundation IA USZF27071
6 · The paper itself

Abstract

The authors wish to make the following corrections to this paper [...].

Identifiers

PMID35805065
PMCPMC9265328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.